España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Fennec Pharmaceuticals
FENC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Fennec Pharmaceuticals (FENC) Forecast
News
Earnings
Fennec Pharmaceuticals (FENC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Fennec Pharmaceuticals (NASDAQ:FENC) Stock
Fennec Pharmaceuticals Stock (NASDAQ: FENC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
Fennec's PEDMARQSI Gains National Institute f...
Benzinga Newsdesk
Thursday, December 19, 2024
Fennec Pharmaceuticals Announced The Early Re...
Benzinga Newsdesk
Tuesday, December 17, 2024
HC Wainwright & Co. Reiterates Buy on Fennec ...
Benzinga Newsdesk
Thursday, November 07, 2024
Fennec Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Fennec Pharmaceuticals Q3 EPS $(0.21) Misses ...
Benzinga Newsdesk
Thursday, August 22, 2024
HC Wainwright & Co. Maintains Buy on Fennec P...
Benzinga Newsdesk
Wednesday, August 14, 2024
Craig-Hallum Maintains Buy on Fennec Pharmace...
Benzinga Newsdesk
Tuesday, August 13, 2024
Fennec Pharmaceuticals Anticipates That Cash ...
Benzinga Newsdesk
Fennec Pharmaceuticals Q2 2024 GAAP EPS $(0.2...
Benzinga Newsdesk
Monday, August 05, 2024
Fennec Appoints Jeff Hackman As Its CEO And A...
Benzinga Newsdesk
Monday, July 01, 2024
Fennec Pharma COO Adrian Haigh Departs, Effec...
Benzinga Newsdesk
Wednesday, May 15, 2024
Craig-Hallum Maintains Buy on Fennec Pharmace...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Fennec P...
Benzinga Newsdesk
Tuesday, May 14, 2024
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Fennec Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Fennec Pharmaceuticals Q1 2024 GAAP EPS $0.41...
Benzinga Newsdesk
Thursday, April 04, 2024
HC Wainwright & Co. Maintains Buy on Fennec P...
Benzinga Newsdesk
Thursday, March 21, 2024
Earnings Scheduled For March 21, 2024
Benzinga Insights
Fennec Pharmaceuticals Q4 EPS $(0.10) Misses ...
Benzinga Newsdesk
Wednesday, March 20, 2024
Fennec Pharmaceuticals's Earnings Outlook
Benzinga Insights
Monday, March 18, 2024
Craig-Hallum Maintains Buy on Fennec Pharmace...
Benzinga Newsdesk
Fennec Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Reported Sunday, Fennec Pharmaceuticals And N...
Benzinga Newsdesk
Thursday, February 29, 2024
Fennec Pharmaceuticals Preliminary Report: Q4...
Benzinga Newsdesk
Thursday, February 01, 2024
Fennec Pharmaceuticals Disclosed That The U.S...
Benzinga Newsdesk
Tuesday, December 05, 2023
Fennec Pharma Announces Incremental $5M Inves...
Benzinga Newsdesk
Monday, November 06, 2023
Earnings Scheduled For November 6, 2023
Benzinga Insights
Fennec Pharmaceuticals Says Cash And Cash Equ...
Benzinga Newsdesk
Fennec Pharmaceuticals Q3 EPS $(0.07) Beats $...
Benzinga Newsdesk
Friday, November 03, 2023
Preview: Fennec Pharmaceuticals's Earnings
Benzinga Insights
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, August 04, 2023
HC Wainwright & Co. Maintains Buy on Fennec P...
Benzinga Newsdesk
Thursday, August 03, 2023
Earnings Scheduled For August 3, 2023
Benzinga Insights
Fennec Pharmaceuticals Q2 EPS $(0.21) Misses ...
Benzinga Newsdesk
Wednesday, June 21, 2023
Analyst Ratings for Fennec Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Fennec ...
Benzinga Newsdesk
Tuesday, June 06, 2023
Fennec Pharmaceuticals Announces European Com...
Benzinga Newsdesk
Thursday, May 11, 2023
Earnings Scheduled For May 11, 2023
Benzinga Insights
Fennec Pharmaceuticals Q1 EPS $(0.23) Misses ...
Benzinga Newsdesk
Recap: Fennec Pharmaceuticals Q1 Earnings
Benzinga Insights
Wednesday, May 10, 2023
Earnings Outlook For Fennec Pharmaceuticals
Benzinga Insights
Thursday, April 06, 2023
Analyst Ratings for Fennec Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Fen...
Benzinga Newsdesk
Tuesday, April 04, 2023
HC Wainwright & Co. Reiterates Buy on Fennec ...
Benzinga Newsdesk
Friday, March 31, 2023
Fennec Receives Positive CHMP Opinion For Ped...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Fennec ...
Benzinga Newsdesk
Monday, February 13, 2023
Fennec Pharmaceuticals Has Also Been Granted A CMS Permanent Product-Specific Reimbursement J-code (J0208) For Pedmark Effective April 1, 2023
Happy Mohamed
Tuesday, January 31, 2023
Fennec Pharmaceuticals Announces PEDMARK Rece...
Bill Haddad
Thursday, January 26, 2023
HC Wainwright & Co. Reiterates Buy on Fennec ...
Benzinga Newsdesk
Wednesday, January 25, 2023
US Stocks Open Lower; Dow Dips 250 Points
Lisa Levin
Show More
